Improving Cognition and Gestational Duration with Targeted Nutrition (COGENT)

计划入组 1,600 人

Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)

计划入组 5,000 人 · 首次发布于 2007 年 11 月 14 日

D-Cycloserine Augmentation of Intermittent Theta Burst Stimulation (iTBS) in Depression (COGENT)

计划入组 180 人 · 首次发布于 2022 年 10 月 24 日

FGFR2-inhibitor (cogent bioscience)

ErbB2 mutant program(Cogent Biosciences)

ACTR 087/rituximab (Cogent Biosciences)

Cogent Biosciences

United States

Cogentus Pharmaceuticals, Inc.

United States

Cagent Vascular, LLC

United States

Cogent Biosciences Unveils Promising KRAS Inhibitor Data with Superior Efficacy Profile

Cogent Biosciences Secures $400M Debt Financing to Advance Bezuclastinib Through Pivotal Trials

Cogent Bio Presents Bezuclastinib Data Highlighting Long-Term Benefits in Non-Advanced Systemic Mastocytosis